TITLE

HIV/AIDS 2001: Latest treatment strategies

AUTHOR(S)
Brown, Billy Ray; Robinson, Marvin
PUB. DATE
March 2001
SOURCE
Drug Topics;3/19/2001, Vol. 145 Issue 6, p39
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Presents updates on the development of treatment strategies for AIDS/HIV in 2001. Classes of antiretrovirals approved by the United States Food and Drug Administration; Study which determined the role of adherence to virologic failures in the majority of patients; Lipid management in HIV.
ACCESSION #
4542519

 

Related Articles

  • Recent Developments in Antiretroviral Therapy. DeSimone, Gary A. // Clinical Journal of Oncology Nursing;Nov/Dec2001, Vol. 5 Issue 6, p1 

    This article reviews the antiretroviral medications in development as presented at the 8th Annual Conference on Retroviruses and Opportunistic Infections. New medications for the treatment of HIV/AIDS are discussed by classification and a brief description of its unique quality is described.

  • Antiretroviral Therapy in AIDS. Broder, Samuel; Mitsuya, Hiroaki; Yarchoam, Robert; Pavlakis, George N. // Annals of Internal Medicine;10/15/90, Vol. 113 Issue 8, p604 

    Discusses the development of antiretroviral therapy for AIDS and related disorders. Summary of a Clinical Staff Conference on October 26, 1988 at the National Institutes of Health; Emergence of drug-resistant virus variants; Description of the activity of 2', 3'-dideoxynucleosides against other...

  • HAART Adherence in Culturally Diverse Patients with HIV/AIDS: A Study of Male Patients from a... Kemppainen, Jeanne K.; Levine, Roger E.; Mistal, Mark; Schmidgall, Donald // AIDS Patient Care & STDs;Mar2001, Vol. 15 Issue 3, p117 

    Identifies the factors influencing adherence to antiretroviral medication regimens in culturally diverse populations with HIV/AIDS related to age, ethnicity and intravenous drug use. Use of the critical incident technique to identify factors determining adherence; Patients most influenced by...

  • ANTI-HIV AGENTS: A STEP TOWARDS FUTURE. Thakur, Devendra Singh; Behera, Chinmay Kumar; Patidar, Ajay; Kumar, Pramod; Kumar, Peeyush; Lal, Champa // International Journal of Pharmaceutical Sciences Review & Resear;Jul-Aug2010, Vol. 3 Issue 2, p10 

    Novel targets for the management of HIV infection have become increasingly relevant in view of extensive drug resistance, side effects and high pill burden of some of the conventional anti-retroviral agents. These agents include chemokine receptor antagonists and the integrase inhibitors which...

  • Progressive Multifocal Leukoencephalopathy in Patients with AIDS Receiving Highly Active... Tantisiriwat, Woraphot; Tebas, Pablo; Clifford, David B.; Powderly, William G.; Fichtenbaum, CArl J. // Clinical Infectious Diseases;5/1/1999, Vol. 28 Issue 5, p1152 

    Reports on cases of progressive multifocal leukoencephalopathy (PML) in HIV-positive patients receiving highly active antiretroviral therapy (HAART). Diagnosis; Clinical symptoms; Medical treatment.

  • Intensification and Stimulation Therapy for Human Immunodeficiency Virus Type 1 Reservoirs in Infected Persons Receiving Virally Suppressive Highly Active Antiretroviral Therapy. Kulkosky, Joseph; Nunnari, Giuseppe; Otero, Miguel; Calarota, Sandra; Dornadula, Geetha; Hui Zhang; Malin, Anne; Sullivan, Julie; Yan Xu; DeSimone, Joseph; Babinchak, Timothy; Stern, John; Cavert, Winston; Haase, Ashley; Pomerantz, Roger J. // Journal of Infectious Diseases;11/15/2002, Vol. 186 Issue 10, p1403 

    Highly active antiretroviral therapy (HAART) has led to significant changes in mortality and morbidity in the human immunodeficiency virus type 1 (HIV-1) epidemic. Nevertheless, because of molecular mechanisms of viral persistence, HAART does not eradicate HIV-1. Didanosine and hydroxyurea were...

  • Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral Eradication. Pomerantz, Roger J. // Clinical Infectious Diseases;1/1/2002, Vol. 34 Issue 1, p91 

    Highly active antiretroviral therapy (HAART) has led to profound decreases in morbidity and mortality rates in human immunodeficiency virus type 1 (HIV-1)--infected persons, at least in the developed world. Many infected persons have plasma levels of HIV-1 RNA that are less than the limits of...

  • Combination therapies against HIV-1 infection: Exploring the concept of combining antiretroviral... Ferre, Francois; Moss, Ronald B. // AIDS Patient Care & STDs;Dec96, Vol. 10 Issue 6, p357 

    Explores the concept of combining antiretroviral drug treatments with HIV-1 immune-based therapies in asymptomatic individuals to combat HIV-1 infection. Effect of antiretroviral drug therapies in asymptomatic individuals; Goal of immune-based therapies; Result of two different treatment.

  • Therapy Adherence and Highly Active Antiretroviral Therapy: Comparison of Three Sources of Information. Vincke, John; Bolton, Ralph // AIDS Patient Care & STDs;Oct2002, Vol. 16 Issue 10, p487 

    With the advent of the highly active antiretroviral therapy (HAART), adherence became one of the key issues within the behavioral management of the treatment of human immunodeficiency virus (HIV) infection. One of the central limitations in studying adherence to HAART is that usually one has to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics